Page last updated: 2024-10-26

famotidine and Chemotherapy-Induced Acral Erythema

famotidine has been researched along with Chemotherapy-Induced Acral Erythema in 1 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Research Excerpts

ExcerptRelevanceReference
"Member institutions of the Japan Breast Cancer Research Group were invited to complete a questionnaire on the occurrence of grade 2 or higher HFS and FE among patients treated between April 2007 and March 2008 with docetaxel as an adjuvant or neoadjuvant chemotherapeutic treatment for breast cancer."1.37Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey. ( Aogi, K; Ishiguro, H; Iwata, H; Kawaguchi, K; Kuroi, K; Masuda, N; Morita, S; Nakamura, S; Ohno, S; Toi, M, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawaguchi, K1
Ishiguro, H1
Morita, S1
Nakamura, S1
Ohno, S1
Masuda, N1
Iwata, H1
Aogi, K1
Kuroi, K1
Toi, M1

Other Studies

1 other study available for famotidine and Chemotherapy-Induced Acral Erythema

ArticleYear
Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution survey.
    Breast cancer research and treatment, 2011, Volume: 130, Issue:2

    Topics: Acetamides; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Docetaxel; Erythema; Famotidine

2011